Drug · DIN 02561832
SEPHIENCE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 1, 2025; first marketed December 1, 2025.
- Drug Identification Number (DIN)
- 02561832
- Company (DIN owner)
- Ptc Therapeutics International LimitedDublin, Ireland
- Schedule
- Prescription
- Dosage form
- Powder
- Route
- Oral
- Therapeutic class (ATC)
- Sepiapterin A16AX28
- Class
- Human
- Record last updated
- June 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SEPIAPTERIN | 1000 MG | SACHET |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 7, 2025: NOC 36125New Drug Submission (NDS)
Other DINs named SEPHIENCE
- DIN 02561824 · Marketed